The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VII.h

Pneumomediastinum

Publications

Kajiyazdi M, Norooznezhad AH

Pneumomediastinum, pneumopericardium and subcutaneous emphysema following acute lymphoblastic leukemia and chemotherapy: A case report.

Caspian journal of internal medicine. 2021;12(Suppl 2):S379-S382

Cruz-Portelles A

Pneumomediastinum after acute lymphoblastic leukemia and chemotherapy?

World journal of clinical cases. 2014;2(5):170-1

Pavlisa G, Planinc-Peraica A, Anic P, Kardum-Skelin I, Pavlisa G, Jaksic B

Pneumomediastinum as a complication to treatment of mediastinal (thymic) large B-cell lymphoma.

Acta radiologica (Stockholm, Sweden : 1987). 2005;46(4):371-3

Chalumeau M, Amigo ME, Delgado R, Grill J, Hartmann O

Pneumomediastinum: a rare, impressive but benign complication of chemotherapy-induced emesis in children.

Medical and pediatric oncology. 1998;31(3):182-4